Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR51894
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Suskiewicz, Marcin; Munnur, Deeksha; Stromland, Oyvind; Yang, Ji-Chun; Easton, Laura; Chatrin, Chatrin; Zhu, Kang; Baretic, Domagoj; Goffinont, Stephane; Schuller, Marion; Wu, Wing-Fung; Elkins, Jonathan; Ahel, Dragana; Sanyal, Sumana; Neuhaus, David; Ahel, Ivan. "Updated protein domain annotation of the PARP protein family sheds new light on biological function" Nucleic Acids Res. 51, 8217-8236 (2023).
PubMed: 37326024
Assembly members:
entity_1, polymer, 1024 residues, Formula weight is not available
entity_2, polymer, 45 residues, Formula weight is not available
entity_ZN, non-polymer, 65.409 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: PQE7
Entity Sequences (FASTA):
entity_1: MKHHHHHHMKQAESSDKLYR
VEYAKSGRASCKKCSESIPK
DSLRMAIMVQSPMFDGKVPH
WYHFSCFWKVGHSIRHPDVE
VDGFSELRWDDQQKVKKTAE
AGGVTGKGQDGIGSKAEKTL
GDFAAEYAKSNRSTCKGCME
KIEKGQVRLSKKMVDPEKPQ
LGMIDRWYHPGCFVKNREEL
GFRPEYSASQLKGFSLLATE
DKEALKKQLPGVKSEGKRKG
DEVDGVDEVAKKKSKKEKDK
DSKLEKALKAQNDLIWNIKD
ELKKVCSTNDLKELLIFNKQ
QVPSGESAILDRVADGMVFG
ALLPCEECSGQLVFKSDAYY
CTGDVTAWTKCMVKTQTPNR
KEWVTPKEFREISYLKKLKV
KKQDRIFPPETSASVAATPP
PSTASAPAAVNSSASADKPL
SNMKILTLGKLSRNKDEVKA
MIEKLGGKLTGTANKASLCI
STKKEVEKMNKKMEEVKEAN
IRVVSEDFLQDVSASTKSLQ
ELFLAHILSPWGAEVKAEPV
EVVAPRGKSGAALSKKSKGQ
VKEEGINKSEKRMKLTLKGG
AAVDPDSGLEHSAHVLEKGG
KVFSATLGLVDIVKGTNSYY
KLQLLEDDKENRYWIFRSWG
RVGTVIGSNKLEQMPSKEDA
IEHFMKLYEEKTGNAWHSKN
FTKYPKKFYPLEIDYGQDEE
AVKKLTVNPGTKSKLPKPVQ
DLIKMIFDVESMKKAMVEYE
IDLQKMPLGKLSKRQIQAAY
SILSEVQQAVSQGSSDSQIL
DLSNRFYTLIPHDFGMKKPP
LLNNADSVQAKAEMLDNLLD
IEVAYSLLRGGSDDSSKDPI
DVNYEKLKTDIKVVDRDSEE
AEIIRKYVKNTHATTHNAYD
LEVIDIFKIEREGECQRYKP
FKQLHNRRLLWHGSRTTNFA
GILSQGLRIAPPEAPVTGYM
FGKGIYFADMVSKSANYCHT
SQGDPIGLILLGEVALGNMY
ELKHASHISKLPKGKHSVKG
LGKTTPDPSANISLDGVDVP
LGTGISSGVNDTSLLYNEYI
VYDIAQVNLKYLLKLKFNFK
TSLW
entity_2: GCTGGCTTCGTAAGAAGCCA
GCTCGCGGTCAGCTTGCTGA
CCGCG
Data type | Count |
15N chemical shifts | 272 |
1H chemical shifts | 272 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | human full-length PARP-1 protein | 1 |
2 | 45 nucleotide DNA dumbbell | 2 |
3 | ZINC ION, 1 | 3 |
4 | ZINC ION, 2 | 3 |
5 | ZINC ION, 3 | 3 |
Entity 1, human full-length PARP-1 protein 1024 residues - Formula weight is not available
The N-terminal residues MKHHHHHHMKQ are non-native (an H6 His tag). The first native PARP1 residue is the immediately following Ala residue, which is Ala 2 of native PARP1.
1 | MET | LYS | HIS | HIS | HIS | HIS | HIS | HIS | MET | LYS | ||||
2 | GLN | ALA | GLU | SER | SER | ASP | LYS | LEU | TYR | ARG | ||||
3 | VAL | GLU | TYR | ALA | LYS | SER | GLY | ARG | ALA | SER | ||||
4 | CYS | LYS | LYS | CYS | SER | GLU | SER | ILE | PRO | LYS | ||||
5 | ASP | SER | LEU | ARG | MET | ALA | ILE | MET | VAL | GLN | ||||
6 | SER | PRO | MET | PHE | ASP | GLY | LYS | VAL | PRO | HIS | ||||
7 | TRP | TYR | HIS | PHE | SER | CYS | PHE | TRP | LYS | VAL | ||||
8 | GLY | HIS | SER | ILE | ARG | HIS | PRO | ASP | VAL | GLU | ||||
9 | VAL | ASP | GLY | PHE | SER | GLU | LEU | ARG | TRP | ASP | ||||
10 | ASP | GLN | GLN | LYS | VAL | LYS | LYS | THR | ALA | GLU | ||||
11 | ALA | GLY | GLY | VAL | THR | GLY | LYS | GLY | GLN | ASP | ||||
12 | GLY | ILE | GLY | SER | LYS | ALA | GLU | LYS | THR | LEU | ||||
13 | GLY | ASP | PHE | ALA | ALA | GLU | TYR | ALA | LYS | SER | ||||
14 | ASN | ARG | SER | THR | CYS | LYS | GLY | CYS | MET | GLU | ||||
15 | LYS | ILE | GLU | LYS | GLY | GLN | VAL | ARG | LEU | SER | ||||
16 | LYS | LYS | MET | VAL | ASP | PRO | GLU | LYS | PRO | GLN | ||||
17 | LEU | GLY | MET | ILE | ASP | ARG | TRP | TYR | HIS | PRO | ||||
18 | GLY | CYS | PHE | VAL | LYS | ASN | ARG | GLU | GLU | LEU | ||||
19 | GLY | PHE | ARG | PRO | GLU | TYR | SER | ALA | SER | GLN | ||||
20 | LEU | LYS | GLY | PHE | SER | LEU | LEU | ALA | THR | GLU | ||||
21 | ASP | LYS | GLU | ALA | LEU | LYS | LYS | GLN | LEU | PRO | ||||
22 | GLY | VAL | LYS | SER | GLU | GLY | LYS | ARG | LYS | GLY | ||||
23 | ASP | GLU | VAL | ASP | GLY | VAL | ASP | GLU | VAL | ALA | ||||
24 | LYS | LYS | LYS | SER | LYS | LYS | GLU | LYS | ASP | LYS | ||||
25 | ASP | SER | LYS | LEU | GLU | LYS | ALA | LEU | LYS | ALA | ||||
26 | GLN | ASN | ASP | LEU | ILE | TRP | ASN | ILE | LYS | ASP | ||||
27 | GLU | LEU | LYS | LYS | VAL | CYS | SER | THR | ASN | ASP | ||||
28 | LEU | LYS | GLU | LEU | LEU | ILE | PHE | ASN | LYS | GLN | ||||
29 | GLN | VAL | PRO | SER | GLY | GLU | SER | ALA | ILE | LEU | ||||
30 | ASP | ARG | VAL | ALA | ASP | GLY | MET | VAL | PHE | GLY | ||||
31 | ALA | LEU | LEU | PRO | CYS | GLU | GLU | CYS | SER | GLY | ||||
32 | GLN | LEU | VAL | PHE | LYS | SER | ASP | ALA | TYR | TYR | ||||
33 | CYS | THR | GLY | ASP | VAL | THR | ALA | TRP | THR | LYS | ||||
34 | CYS | MET | VAL | LYS | THR | GLN | THR | PRO | ASN | ARG | ||||
35 | LYS | GLU | TRP | VAL | THR | PRO | LYS | GLU | PHE | ARG | ||||
36 | GLU | ILE | SER | TYR | LEU | LYS | LYS | LEU | LYS | VAL | ||||
37 | LYS | LYS | GLN | ASP | ARG | ILE | PHE | PRO | PRO | GLU | ||||
38 | THR | SER | ALA | SER | VAL | ALA | ALA | THR | PRO | PRO | ||||
39 | PRO | SER | THR | ALA | SER | ALA | PRO | ALA | ALA | VAL | ||||
40 | ASN | SER | SER | ALA | SER | ALA | ASP | LYS | PRO | LEU | ||||
41 | SER | ASN | MET | LYS | ILE | LEU | THR | LEU | GLY | LYS | ||||
42 | LEU | SER | ARG | ASN | LYS | ASP | GLU | VAL | LYS | ALA | ||||
43 | MET | ILE | GLU | LYS | LEU | GLY | GLY | LYS | LEU | THR | ||||
44 | GLY | THR | ALA | ASN | LYS | ALA | SER | LEU | CYS | ILE | ||||
45 | SER | THR | LYS | LYS | GLU | VAL | GLU | LYS | MET | ASN | ||||
46 | LYS | LYS | MET | GLU | GLU | VAL | LYS | GLU | ALA | ASN | ||||
47 | ILE | ARG | VAL | VAL | SER | GLU | ASP | PHE | LEU | GLN | ||||
48 | ASP | VAL | SER | ALA | SER | THR | LYS | SER | LEU | GLN | ||||
49 | GLU | LEU | PHE | LEU | ALA | HIS | ILE | LEU | SER | PRO | ||||
50 | TRP | GLY | ALA | GLU | VAL | LYS | ALA | GLU | PRO | VAL | ||||
51 | GLU | VAL | VAL | ALA | PRO | ARG | GLY | LYS | SER | GLY | ||||
52 | ALA | ALA | LEU | SER | LYS | LYS | SER | LYS | GLY | GLN | ||||
53 | VAL | LYS | GLU | GLU | GLY | ILE | ASN | LYS | SER | GLU | ||||
54 | LYS | ARG | MET | LYS | LEU | THR | LEU | LYS | GLY | GLY | ||||
55 | ALA | ALA | VAL | ASP | PRO | ASP | SER | GLY | LEU | GLU | ||||
56 | HIS | SER | ALA | HIS | VAL | LEU | GLU | LYS | GLY | GLY | ||||
57 | LYS | VAL | PHE | SER | ALA | THR | LEU | GLY | LEU | VAL | ||||
58 | ASP | ILE | VAL | LYS | GLY | THR | ASN | SER | TYR | TYR | ||||
59 | LYS | LEU | GLN | LEU | LEU | GLU | ASP | ASP | LYS | GLU | ||||
60 | ASN | ARG | TYR | TRP | ILE | PHE | ARG | SER | TRP | GLY | ||||
61 | ARG | VAL | GLY | THR | VAL | ILE | GLY | SER | ASN | LYS | ||||
62 | LEU | GLU | GLN | MET | PRO | SER | LYS | GLU | ASP | ALA | ||||
63 | ILE | GLU | HIS | PHE | MET | LYS | LEU | TYR | GLU | GLU | ||||
64 | LYS | THR | GLY | ASN | ALA | TRP | HIS | SER | LYS | ASN | ||||
65 | PHE | THR | LYS | TYR | PRO | LYS | LYS | PHE | TYR | PRO | ||||
66 | LEU | GLU | ILE | ASP | TYR | GLY | GLN | ASP | GLU | GLU | ||||
67 | ALA | VAL | LYS | LYS | LEU | THR | VAL | ASN | PRO | GLY | ||||
68 | THR | LYS | SER | LYS | LEU | PRO | LYS | PRO | VAL | GLN | ||||
69 | ASP | LEU | ILE | LYS | MET | ILE | PHE | ASP | VAL | GLU | ||||
70 | SER | MET | LYS | LYS | ALA | MET | VAL | GLU | TYR | GLU | ||||
71 | ILE | ASP | LEU | GLN | LYS | MET | PRO | LEU | GLY | LYS | ||||
72 | LEU | SER | LYS | ARG | GLN | ILE | GLN | ALA | ALA | TYR | ||||
73 | SER | ILE | LEU | SER | GLU | VAL | GLN | GLN | ALA | VAL | ||||
74 | SER | GLN | GLY | SER | SER | ASP | SER | GLN | ILE | LEU | ||||
75 | ASP | LEU | SER | ASN | ARG | PHE | TYR | THR | LEU | ILE | ||||
76 | PRO | HIS | ASP | PHE | GLY | MET | LYS | LYS | PRO | PRO | ||||
77 | LEU | LEU | ASN | ASN | ALA | ASP | SER | VAL | GLN | ALA | ||||
78 | LYS | ALA | GLU | MET | LEU | ASP | ASN | LEU | LEU | ASP | ||||
79 | ILE | GLU | VAL | ALA | TYR | SER | LEU | LEU | ARG | GLY | ||||
80 | GLY | SER | ASP | ASP | SER | SER | LYS | ASP | PRO | ILE | ||||
81 | ASP | VAL | ASN | TYR | GLU | LYS | LEU | LYS | THR | ASP | ||||
82 | ILE | LYS | VAL | VAL | ASP | ARG | ASP | SER | GLU | GLU | ||||
83 | ALA | GLU | ILE | ILE | ARG | LYS | TYR | VAL | LYS | ASN | ||||
84 | THR | HIS | ALA | THR | THR | HIS | ASN | ALA | TYR | ASP | ||||
85 | LEU | GLU | VAL | ILE | ASP | ILE | PHE | LYS | ILE | GLU | ||||
86 | ARG | GLU | GLY | GLU | CYS | GLN | ARG | TYR | LYS | PRO | ||||
87 | PHE | LYS | GLN | LEU | HIS | ASN | ARG | ARG | LEU | LEU | ||||
88 | TRP | HIS | GLY | SER | ARG | THR | THR | ASN | PHE | ALA | ||||
89 | GLY | ILE | LEU | SER | GLN | GLY | LEU | ARG | ILE | ALA | ||||
90 | PRO | PRO | GLU | ALA | PRO | VAL | THR | GLY | TYR | MET | ||||
91 | PHE | GLY | LYS | GLY | ILE | TYR | PHE | ALA | ASP | MET | ||||
92 | VAL | SER | LYS | SER | ALA | ASN | TYR | CYS | HIS | THR | ||||
93 | SER | GLN | GLY | ASP | PRO | ILE | GLY | LEU | ILE | LEU | ||||
94 | LEU | GLY | GLU | VAL | ALA | LEU | GLY | ASN | MET | TYR | ||||
95 | GLU | LEU | LYS | HIS | ALA | SER | HIS | ILE | SER | LYS | ||||
96 | LEU | PRO | LYS | GLY | LYS | HIS | SER | VAL | LYS | GLY | ||||
97 | LEU | GLY | LYS | THR | THR | PRO | ASP | PRO | SER | ALA | ||||
98 | ASN | ILE | SER | LEU | ASP | GLY | VAL | ASP | VAL | PRO | ||||
99 | LEU | GLY | THR | GLY | ILE | SER | SER | GLY | VAL | ASN | ||||
100 | ASP | THR | SER | LEU | LEU | TYR | ASN | GLU | TYR | ILE | ||||
101 | VAL | TYR | ASP | ILE | ALA | GLN | VAL | ASN | LEU | LYS | ||||
102 | TYR | LEU | LEU | LYS | LEU | LYS | PHE | ASN | PHE | LYS | ||||
103 | THR | SER | LEU | TRP |
Entity 2, 45 nucleotide DNA dumbbell 45 residues - Formula weight is not available
1 | DG | DC | DT | DG | DG | DC | DT | DT | DC | DG | ||||
2 | DT | DA | DA | DG | DA | DA | DG | DC | DC | DA | ||||
3 | DG | DC | DT | DC | DG | DC | DG | DG | DT | DC | ||||
4 | DA | DG | DC | DT | DT | DG | DC | DT | DG | DA | ||||
5 | DC | DC | DG | DC | DG |
Entity 3, ZINC ION, 1 - Zn - 65.409 Da.
1 | ZN |
sample_1: human full-length PARP-1 protein, [U-15N], 0.0355 mM; sodium phosphate 10 mM; sodium chloride 222 mM; potassium chloride 2.7 mM; DTT, [U-2H], 2 mM; DNA_(45-MER) 0.04 mM
sample_conditions_1: ionic strength: 0.2747 M; pH: 7.4; pressure: 1 atm; temperature: 298 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
2D 1H-15N TROSY | sample_1 | isotropic | sample_conditions_1 |
TOPSPIN v3.2 - collection, processing
SPARKY v3.115 - chemical shift assignment
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks